Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients
Egyptian Journal of Hospital Medicine [The]. 2018; 71 (2): 2590-2592
in En
| IMEMR
| ID: emr-192503
Responsible library:
EMRO
ABSTRACT
Background:
Breast cancer is increasingly regarded as a heterogeneous disease which can be classified into distinct molecular subtypes with prognosticsignificance:
Search on Google
Index:
IMEMR
Main subject:
Breast Neoplasms
/
Retrospective Studies
/
Genes, erbB-2
/
Neoadjuvant Therapy
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Egypt. J. Hosp. Med.
Year:
2018